| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |